HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report

HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.

Detalles Bibliográficos
Autores principales: Yasuda, Taisei, Osaki, Masami, Sugitani, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593971/
https://www.ncbi.nlm.nih.gov/pubmed/37881200
http://dx.doi.org/10.1002/ccr3.8099
_version_ 1785124547283910656
author Yasuda, Taisei
Osaki, Masami
Sugitani, Masahiko
author_facet Yasuda, Taisei
Osaki, Masami
Sugitani, Masahiko
author_sort Yasuda, Taisei
collection PubMed
description HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.
format Online
Article
Text
id pubmed-10593971
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105939712023-10-25 HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report Yasuda, Taisei Osaki, Masami Sugitani, Masahiko Clin Case Rep Case Report HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib. John Wiley and Sons Inc. 2023-10-23 /pmc/articles/PMC10593971/ /pubmed/37881200 http://dx.doi.org/10.1002/ccr3.8099 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yasuda, Taisei
Osaki, Masami
Sugitani, Masahiko
HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_full HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_fullStr HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_full_unstemmed HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_short HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
title_sort hras mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593971/
https://www.ncbi.nlm.nih.gov/pubmed/37881200
http://dx.doi.org/10.1002/ccr3.8099
work_keys_str_mv AT yasudataisei hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport
AT osakimasami hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport
AT sugitanimasahiko hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport

Ejemplares similares